Naltrexone in the treatment of alcohol dependence.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  The Annals of Pharmacotherapy

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0741-8329(94)90014-0PMID 8173139
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• International update: new findings on promising medications.

  1996cited by this paper
• Implications of endogenous opioids and dopamine in alcoholism: human and basic science studies.

  1996cited by this paper
• Experience of a "slip" among alcoholics treated with naltrexone or placebo.

  1996cited by this paper
• Naltrexone in the Treatment of Alcohol Dependence: A Combined Analysis of Two Trials

  1995cited by this paper
• The Obsessive Compulsive Drinking Scale: a self-rated instrument for the quantification of thoughts about alcohol and drinking behavior.

  1995cited by this paper
• Effect of naltrexone on alcohol "high" in alcoholics.

  1995cited by this paper
• Naltrexone-induced alterations in human ethanol intoxication.

  1994cited by this paper
• Naltrexone and coping skills therapy for alcohol dependence. A controlled study.

  1992cited by this paper
• Naltrexone in the treatment of alcohol dependence.

  1992cited by this paper
• Stages of change profiles in outpatient alcoholism treatment.

  1990cited by this paper
• Prospects for a rational pharmacotherapy of alcoholism.

  1989cited by this paper
• Reliability of a timeline method: assessing normal drinkers' reports of recent drinking and a comparative evaluation across several populations.

  1988cited by this paper
• Emerging treatment options in the alcohol withdrawal syndrome.

  1988cited by this paper
• Constant infusions of morphine and intakes of sweetened ethanol solution among rats.

  1988cited by this paper
• A double-blind, placebo-controlled trial of lithium carbonate therapy for alcoholism.

  1987cited by this paper
• Disulfiram Treatment of Alcoholism: A Veterans Administration Cooperative Study

  1986cited by this paper
• Modulation of ethanol intake by serotonin uptake inhibitors.

  1986cited by this paper
• Oral ethanol self-administration in the rat: effect of naloxone.

  1985cited by this paper
• Compliance with disulfiram treatment of alcoholism.

  1983cited by this paper
• Alcohol dependence syndrome: measurement and validation.

  1982cited by this paper
• Alteration of ethanol self-administration by naltrexone.

  1980cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper

• Development of a liquid chromatography-tandem mass spectrometry method for the analysis of plasma naltrexone and its active metabolite in patients with AUD

  2025cites this paper
• Naltrexone Alters Neurochemical and Behavioral Parameters in a Zebrafish Model of Repeated Alcohol Exposure

  2025cites this paper
• Treatment-Resistant Depression (TRD): Is the Opioid System Involved?

  2023cites this paper
• “It’s about being healthy”; a novel approach to the socio-ecological model using family perspectives within the Latinx community

  2023cites this paper
• Pharmacological Treatment of Alcohol use Disorder in Patients with Psychotic Disorders: A Systematic Review

  2022cites this paper
• Prevalence and Treatment for Alcohol Use Disorders Based on Kentucky Medicaid 2012–2019 Datasets

  2022cites this paper
• Metacognitive deficits are associated with lower sensitivity to preference reversals in nicotine dependence

  2022cites this paper
• Looking Back, Looking Forward: Current Medications and Innovative Potential Medications to Treat Alcohol Use Disorder

  2022cites this paper
• Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder

  2022cites this paper
• The Added Value of Pharmacotherapy to Cognitive Behavior Therapy And Vice Versa in the Treatment of Alcohol Use Disorders: A Systematic Review

  2022influential citation
• Determination of the Relationship Between Craving and 4-repeat Allele of DRD4 Gene Polymorphism in the Early Withdrawal Period of Alcohol Use Disorders

  2021cites this paper
• The Role of Social Stress in the Development of Inhibitory Control Deficit: A Systematic Review in Preclinical Models

  2021cites this paper
• Translational opportunities in animal and human models to study alcohol use disorder

  2021cites this paper
• Pharmakologische Rückfallprophylaxe der Alkoholabhängigkeit

  2021cites this paper
• Psychedelic treatment for co-occurring alcohol misuse and post-traumatic stress symptoms among United States Special Operations Forces Veterans

  2021cites this paper
• Opioid antagonism reduces wanting by strengthening frontostriatal connectivity

  2021cites this paper
• Can intranasal oxytocin reduce craving in automated addictive behaviours? A systematic review

  2021cites this paper
• Impact of Continuing Care on Recovery From Substance Use Disorder

  2021cites this paper
• Developmental Considerations for the Use of Naltrexone in Children and Adolescents.

  2021cites this paper
• Disrupted circadian expression of β‐arrestin 2 affects reward‐related µ‐opioid receptor function in alcohol dependence

  2021cites this paper
• Nalmefene attenuates neural alcohol cue-reactivity in the ventral striatum and subjective alcohol craving in patients with alcohol use disorder

  2021cites this paper
• Understanding the Neurocomputational Mechanisms of Antidepressant Placebo Effects

  2021cites this paper
• Long Term Pharmacotherapy for Alcohol Use Disorder

  2020cites this paper
• Treating Alcohol Use Disorder in Chronic Liver Disease

  2020cites this paper
• Badania nad głodem alkoholowym: implikacje do leczenia

  2020cites this paper
• Behavioural and physiological correlates of immersion in gambling using electronic gaming machines

  2020cites this paper
• Pharmacotherapy of alcohol withdrawal : update and new developments

  2020cites this paper
• Improving naltrexone compliance and outcomes with putative pro- dopamine regulator KB220, compared to treatment as usual

  2020cites this paper
• Pharmakotherapie der Alkoholentwöhnung: Update und neue Entwicklungen

  2020cites this paper
• The Persistent Challenge of Developing Addiction Pharmacotherapies.

  2020cites this paper
• Bi-directional Acceleration of Alcohol Use and Opioid Use Disorder

  2019cites this paper
• Contributions of µ- and κ-opioidergic systems to ethanol intake and addiction

  2019influential citation
• Neurobiological Basis of Craving and Anti-Craving Medications

  2019cites this paper
• Panorama actual del trastorno por consumo de tabaco

  2019cites this paper
• Synaptic effects of ethanol on the agranular insunlar cortex

  2019cites this paper
• State-of-the-Art Treatment of Alcohol Use Disorder

  2019cites this paper
• Directorate for Employment, Labour and Social Affairs

  2019cites this paper
• Building better strategies to develop new medications in Alcohol Use Disorder: Learning from past success and failure to shape a brighter future.

  2019cites this paper
• Effectiveness, Implementation and Real-World Experience with Extended-Release Naltrexone (XR-NTX): A Special Issue of JSAT.

  2018cites this paper
• Testing Mediators of Reduced Drinking for Veterans in Alcohol Care Management.

  2018cites this paper
• Persistent effects of obesity: a neuroplasticity hypothesis

  2018cites this paper
• A randomized controlled study of the effect of ifenprodil on alcohol use in patients with alcohol dependence

  2018cites this paper
• Gambling addiction

  2018cites this paper
• Exploring sex differences in the prevention of ethanol drinking by naltrexone in dependent rats during abstinence

  2018cites this paper
• Naltrexone: A History and Future Directions

  2018cites this paper
• Adding Psychotherapy to the Naltrexone Treatment of Alcohol Use Disorder: Meta-analytic Review

  2018cites this paper
• The Black Book of Psychotropic Dosing and Monitoring.

  2018cites this paper
• Predictors of Daily Adherence to Naltrexone for Alcohol Use Disorder Treatment During a Mobile Health Intervention.

  2018cites this paper
• State-ofthe-art behavioral and pharmacological treatments for alcohol use disorder

  2018cites this paper
• The safety of pharmacologic treatment for pediatric obesity

  2018cites this paper
• Ethanol actions on the ventral tegmental area: novel potential targets on reward pathway neurons

  2018cites this paper
• Compounds Including Cox Inhibitor Moiety and Enhanced Delivery of Active Drugs Using Same

  2018cites this paper
• Belohnung und das Opioidsystem

  2018cites this paper
• Involvement of Activated Brain Stress Responsive Systems in Excessive and “Relapse” Alcohol Drinking in Rodent Models: Implications for Therapeutics

  2018cites this paper
• Trial of Prazosin for Post‐Traumatic Stress Disorder in Military Veterans

  2018cites this paper
• Medications development for the treatment of alcohol use disorder: insights into the predictive value of animal and human laboratory models

  2017cites this paper
• Efficacy of long-acting, injectable versus oral naltrexone for preventing admissions for alcohol use disorder.

  2017cites this paper
• Sudden unexpected death in epilepsy

  2017cites this paper
• Synergistic blockade of alcohol escalation drinking in mice by a combination of novel kappa opioid receptor agonist Mesyl Salvinorin B and naltrexone.

  2017cites this paper
• Pharmacotherapy of alcoholism – an update on approved and off-label medications

  2017cites this paper
• Increased ethanol drinking in "humanized" mice expressing the mu opioid receptor A118G polymorphism are mediated through sex-specific mechanisms.

  2017influential citation
• Alcohol, stress, and glucocorticoids: From risk to dependence and relapse in alcohol use disorders

  2017cites this paper
• Naltrexone Inhibits IL-6 and TNFα Production in Human Immune Cell Subsets following Stimulation with Ligands for Intracellular Toll-Like Receptors

  2017cites this paper
• Naltrexone efficacy in treating alcohol-use disorder in individuals with comorbid psychosis: a systematic review

  2017cites this paper
• Feeding-modulatory effects of mu-opioids in the medial prefrontal cortex: a review of recent findings and comparison to opioid actions in the nucleus accumbens

  2017cites this paper
• Reduced Drinking in Alcohol Dependence Treatment, What Is the Evidence?

  2017cites this paper
• Food–alcohol competition: As young females eat more food, do they drink less alcohol?

  2017cites this paper
• Treatment modalities for patients with gambling disorder

  2017cites this paper
• Guidelines for the understanding and management of pain in chronic pancreatitis.

  2017cites this paper
• Hypothalamic‐specific proopiomelanocortin deficiency reduces alcohol drinking in male and female mice

  2017cites this paper
• Current Treatment Options for Co-Morbid Anxiety and Alcohol Use Disorders: A Review

  2017cites this paper
• A Randomized Controlled Trial of Cognitive Remediation and Work Therapy in the Early Phase of Substance Use Disorder Recovery for Older Veterans: Neurocognitive and Substance Use Outcomes

  2017influential citation
• 12 Pharmacogenetics – A Treatment Strategy for Alcoholism

  2017cites this paper
• Predictors of Naltrexone Response in a Randomized Trial: Reward-Related Brain Activation, OPRM1 Genotype, and Smoking Status

  2017cites this paper
• Risk factors and outcomes associated with alcohol relapse after liver transplantation

  2017cites this paper
• Nowe leki wykorzystywane w zaburzeniach związanych z używaniem substancji psychoaktywnych

  2016cites this paper
• Current Insights into the Mechanisms and Development of Treatments for Heavy-Drinking Cigarette Smokers

  2016cites this paper
• Functional imaging of neural systems associated with alcohol reward and amphetamine toxicity

  2016cites this paper
• The association between depression and craving in alcohol dependency is moderated by gender and by alexithymia factors.

  2016cites this paper
• Addictions Neuroclinical Assessment: A Neuroscience-Based Framework for Addictive Disorders.

  2016cites this paper
• Dissociation of μ‐opioid receptor and CRF‐R1 antagonist effects on escalated ethanol consumption and mPFC serotonin in C57BL/6J mice

  2016cites this paper
• TIP 49: Incorporating Alcohol Pharmacotherapies Into Medical Practice

  2016cites this paper
• Does the combination of buprenorphine/naltrexone have antidepressant efficacy in animal models?

  2016cites this paper
• Food cue reactivity and craving predict eating and weight gain: a meta‐analytic review

  2016cites this paper
• Extended-Release Naltrexone: A Qualitative Analysis of Barriers to Routine Use.

  2016cites this paper
• Tratamientos farmacológicos en la coadministración de alcohol y cocaína: efectos en la expresión de genes en el córtex prefrontal de la rata

  2016cites this paper
• Correlates of Homeless Youths’ Stability-Seeking Behaviors Online and In Person

  2016cites this paper
• Weak evidence on nalmefene creates dilemmas for clinicians and poses questions for regulators and researchers

  2016cites this paper
• Evaluation of the “Pipeline” for Development of Medications for Cocaine Use Disorder: A Review of Translational Preclinical, Human Laboratory, and Clinical Trial Research

  2016cites this paper
• Naltrexone: A Pan-Addiction Treatment?

  2016influential citation
• Nauka o układzie nerwowym a wprowadzanie nowych leków

  2016cites this paper
• From unwitnessed fatality to witnessed rescue: Pharmacologic intervention in sudden unexpected death in epilepsy

  2016cites this paper
• Gr upSM Opioid Receptor Antagonists and Alcohol Dependence Treatment PART

  2016cites this paper
• Naltrexone alters the processing of social and emotional stimuli in healthy adults

  2016cites this paper
• Kappa‐opioid receptors differentially regulate low and high levels of ethanol intake in female mice

  2016cites this paper
• What does addiction medicine expect from neuroscience ? From genes and neurons to treatment responses 19

  2016cites this paper
• Modulation of nucleus accumbens connectivity by alcohol drinking and naltrexone in alcohol-preferring rats: A manganese-enhanced magnetic resonance imaging study.

  2016cites this paper
• Are Alcohol Anti-relapsing and Alcohol Withdrawal Drugs Useful in Cannabinoid Users?

  2016cites this paper
• A sudden and unprecedented increase in low dose naltrexone (LDN) prescribing in Norway. Patient and prescriber characteristics, and dispense patterns. A drug utilization cohort study

  2016cites this paper
• Low-Dose naltrexone in diseases’ treatment : global review

  2016cites this paper